{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:56:37Z","timestamp":1790006197019,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["#HNF1410-18"],"award-info":[{"award-number":["#HNF1410-18"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007137","name":"Northern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["#HNF1540-20"],"award-info":[{"award-number":["#HNF1540-20"]}],"id":[{"id":"10.13039\/501100007137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013263","name":"Nasjonalforeningen for Folkehelsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","award":["311993"],"award-info":[{"award-number":["311993"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neurobiolaging.2025.07.005","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T12:33:21Z","timestamp":1752582801000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomes"],"prefix":"10.1016","volume":"155","author":[{"given":"Grit","family":"Richter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn-Eivind","family":"Kirsebom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Alexander","family":"Jarholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"P\u00e5lhaugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berglind","family":"G\u00edslad\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f8ril Rolfseng","family":"Gr\u00f8ntvedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild Eide","family":"Skogseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Waterloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tormod","family":"Fladby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5897-6394","authenticated-orcid":false,"given":"Kaja","family":"Nordengen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.07.005_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the national institute on aging-alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer'S. Dement. J. Alzheimer'S. Assoc."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib3","article-title":"Controlled oral word association","author":"Benton","year":"1989","journal-title":"Multiling. Aphasia Exam. AJA Assoc. Iowa USA"},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1326-7-52","article-title":"BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and \u03b2-amyloid production in Alzheimer's disease","volume":"7","author":"Chami","year":"2012","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib5","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3233\/JAD-160227","article-title":"The cerebrospinal fluid neurogranin\/BACE1 ratio is a potential correlate of cognitive decline in alzheimer's disease","volume":"53","author":"De Vos","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib7","article-title":"Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease","volume":"12","author":"Dhiman","year":"2020","journal-title":"Alzheimers Dement (Amst."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.07.005_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa177","article-title":"Grey matter network trajectories across the Alzheimer's disease continuum and relation to cognition","volume":"2","author":"Dicks","year":"2020","journal-title":"Brain Commun."},{"issue":"S5","key":"10.1016\/j.neurobiolaging.2025.07.005_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/alz.055891","article-title":"How to define \u2018N\u2019 in the ATN classification in subjective cognitive decline: The SCIENCe project","volume":"17","author":"Ebenau","year":"2021","journal-title":"Alzheimer'S. Dement."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.07.005_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1037\/neu0000698","article-title":"Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer's pathology and progression to dementia","volume":"34","author":"Eliassen","year":"2020","journal-title":"Neuropsychology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/neu0000853","article-title":"Regression-based cognitive change norms applied in biochemically defined predementia Alzheimer's disease","volume":"37","author":"Eliassen","year":"2023","journal-title":"Neuropsychology"},{"issue":"sup1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/13854046.2020.1829068","article-title":"Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years","volume":"34","author":"Espenes","year":"2020","journal-title":"Clin. Neuropsychol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.07.005_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jalz.2007.08.005","article-title":"Consortium to establish a registry for Alzheimer's Disease (CERAD): the first twenty years","volume":"4","author":"Fillenbaum","year":"2008","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-170231","article-title":"Detecting at-risk Alzheimer's disease cases","volume":"60","author":"Fladby","year":"2017","journal-title":"J. Alzheimer'S. Dis. JAD"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13195-018-0339-1","article-title":"A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation","volume":"10","author":"Gaetani","year":"2018","journal-title":"Alzheimers Res Ther."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.07.005_bib16","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.07.005_bib17","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.neurobiolaging.2015.06.027","article-title":"Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype","volume":"36","author":"Gispert","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106267","article-title":"Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia","volume":"186","author":"Giuffr\u00e8","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib19","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1038\/s41467-024-47286-5","article-title":"Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer\u2019s disease","volume":"15","author":"Gonzalez-Ortiz","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.07.005_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mds.27950","article-title":"Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders","volume":"35","author":"Hall","year":"2020","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.31887\/DCNS.2004.6.4\/hhampel","article-title":"CSF tau and \u03b2-amyloid as biomarkers for mild cognitive impairment","volume":"6","author":"Hampel","year":"2004","journal-title":"Dialog. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer's disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib23","unstructured":"Heaton, R.K. (2004). Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults, professional manual. Psychological Assessment Resources."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.07.005_bib25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1212\/WNL.52.7.1397","article-title":"Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment","volume":"52","author":"Jack","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13859","article-title":"Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup","author":"Jack","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.07.005_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimer'S. Dement. J. Alzheimer'S. Assoc."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.07.005_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.07.005_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","article-title":"The Alzheimer's \u03b2-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques","volume":"126","author":"Kandalepas","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.07.005_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jamaneurol.2018.3459","article-title":"Association of cerebrospinal fluid neurofilament light protein with risk of mild cognitive impairment among individuals without cognitive impairment","volume":"76","author":"Kern","year":"2019","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.07.005_bib32","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jamaneurol.2015.1867","article-title":"Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer Disease","volume":"72","author":"Kester","year":"2015","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.07.005_bib33","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"sup1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13854046.2019.1574902","article-title":"Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years","volume":"33","author":"Kirsebom","year":"2019","journal-title":"Clin. Neuropsychol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.07.005_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac244","article-title":"Stable cerebrospinal fluid neurogranin and \u03b2-site amyloid precursor protein cleaving enzyme 1 levels differentiate predementia Alzheimer's disease patients","volume":"4","author":"Kirsebom","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2024.05.016","article-title":"Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease","volume":"141","author":"Knudtzon","year":"2024","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.07.005_bib37","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jalz.2014.10.009","article-title":"Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease","volume":"11","author":"Kvartsberg","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-018-1910-3","article-title":"The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease","volume":"137","author":"Kvartsberg","year":"2019","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib40","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-024-00755-3","article-title":"Clarifying the association of CSF A\u03b2, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer disease","volume":"19","author":"Lehmann","year":"2024","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41398-020-0801-2","article-title":"Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer's disease and mild cognitive impairment","volume":"10","author":"Liu","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.07.005_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/23279095.2021.1918128","article-title":"Regression-based norms for the FAS phonemic fluency test for ages 40-84 based on a Norwegian sample","volume":"30","author":"Lorentzen","year":"2023","journal-title":"Appl. Neuropsychol. Adult"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13195-021-00944-y","article-title":"Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes","volume":"13","author":"Marks","year":"2021","journal-title":"Alzheimers Res Ther."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.07.005_bib44","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/emmm.201606540","article-title":"Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease","volume":"8","author":"Mattsson","year":"2016","journal-title":"EMBO Mol. Med"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.07.005_bib45","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"issue":"16","key":"10.1016\/j.neurobiolaging.2025.07.005_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","article-title":"A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease","volume":"6","author":"Mattsson-Carlgren","year":"2020","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.07.005_bib47","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105662","article-title":"Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage","volume":"166","author":"Meeker","year":"2022","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.07.005_bib49","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.07.005_bib50","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/alz.12239","article-title":"Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers","volume":"17","author":"Mielke","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.07.005_bib51","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/alz.12131","article-title":"Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum","volume":"16","author":"Mil\u00e0-Alom\u00e0","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib52","article-title":"Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease","volume":"13","author":"Nilsson","year":"2021","journal-title":"Alzheimers Dement (Amst."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.07.005_bib53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","article-title":"CSF and blood biomarkers for Parkinson's disease","volume":"18","author":"Parnetti","year":"2019","journal-title":"Lancet Neurol."},{"issue":"Pt 11","key":"10.1016\/j.neurobiolaging.2025.07.005_bib54","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/brain\/awv267","article-title":"Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease","volume":"138","author":"Portelius","year":"2015","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.07.005_bib55","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1523\/JNEUROSCI.10-12-03782.1990","article-title":"Neurogranin: immunocytochemical localization of a brain-specific protein kinase C substrate","volume":"10","author":"Represa","year":"1990","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuron.2018.04.035","article-title":"Tau kinetics in neurons and the human central nervous system","volume":"98","author":"Sato","year":"2018","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.07.005_bib57","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/brain\/awab372","article-title":"Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease","volume":"145","author":"Schumacher","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib58","article-title":"Association of CSF biomarkers with MRI brain changes in Alzheimer's disease","volume":"16","author":"Seidu","year":"2024","journal-title":"Alzheimers Dement (Amst."},{"issue":"8","key":"10.1016\/j.neurobiolaging.2025.07.005_bib59","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-\u03b2 protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99794-9","article-title":"Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression","volume":"11","author":"Siafarikas","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.07.005_bib61","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.neurobiolaging.2011.02.022","article-title":"CSF tau markers are correlated with hippocampal volume in Alzheimer's disease","volume":"33","author":"de Souza","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.07.005_bib62","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/jamaneurol.2016.0086","article-title":"Diagnostic and prognostic utility of the synaptic marker neurogranin in Alzheimer disease","volume":"73","author":"Tarawneh","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2010.09.073","article-title":"Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease","volume":"1362","author":"Thorsell","year":"2010","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib64","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer's disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab272","article-title":"Loss and dispersion of superficial white matter in Alzheimer's disease: a diffusion MRI study","volume":"3","author":"Veale","year":"2021","journal-title":"Brain Commun."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2025.07.005_bib66","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1080\/00207454.2021.1881087","article-title":"The synaptic marker neurogranin as a disease state biomarker in Alzheimer's disease: a systematic review and meta-analysis","volume":"132","author":"Wang","year":"2022","journal-title":"Int J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib67","unstructured":"Warrington, E.K. (1991). Visual object and space perception battery. (No Title)."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.07.005_bib68","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to Alzheimer disease","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105486","article-title":"Altered synaptic glutamate homeostasis contributes to cognitive decline in young APP\/PSEN1 mice","volume":"158","author":"Wilcox","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.07.005_bib70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2021.08.002","article-title":"Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia","volume":"108","author":"Willemse","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib71","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.07.005_bib72","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol."},{"issue":"14","key":"10.1016\/j.neurobiolaging.2025.07.005_bib74","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1523\/JNEUROSCI.4396-06.2007","article-title":"Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis","volume":"27","author":"Zhao","year":"2007","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.07.005_bib75","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-72168-3","article-title":"Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease","volume":"10","author":"Zuliani","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:52:46Z","timestamp":1777528366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458025001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":75,"alternative-id":["S0197458025001198"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.07.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomes","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}